Literature DB >> 7781383

Fluoxetine hydrochloride (Prozac)-induced pulmonary disease.

R J Gonzalez-Rothi1, D S Zander, P R Ros.   

Abstract

We describe a patient who developed progressive dyspnea, lung infiltrates, and restrictive lung disease in association with the antidepressant fluoxetine hydrochloride (Prozac). The pathologic findings were consistent with hypersensitivity pneumonitis. An associated pulmonary phospholipidosis was also noted.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7781383     DOI： 10.1378/chest.107.6.1763

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  12 in total

1.  Simulation-based cheminformatic analysis of organelle-targeted molecules: lysosomotropic monobasic amines.

Authors:  Xinyuan Zhang; Nan Zheng; Gus R Rosania
Journal:  J Comput Aided Mol Des       Date:  2008-03-13       Impact factor: 3.686

2.  Pulmonary fibrosis associated with psychotropic drug therapy: a case report.

Authors:  Clare Thornton; Toby M Maher; David Hansell; Andrew G Nicholson; Athol U Wells
Journal:  J Med Case Rep       Date:  2009-11-16

3.  A Very Rare Adverse Effect of Clozapine, Clozapine-induced Interstitial Lung Disease: Case Report and Literature Review.

Authors:  Kazım Cihan Can; Demet Karnak; Halise devrİmcİ Özgüven
Journal:  Noro Psikiyatr Ars       Date:  2019-10-04       Impact factor: 1.339

4.  Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening.

Authors:  Eleonore Fröhlich
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Pathology and Neurotoxicity in Dogs after Repeat Dose Exposure to a Serotonin 5-HT1B Inhibitor.

Authors:  Jane C F Chang; Paul Ciaccio; Patricia Schroeder; Lindsay Wright; Russell Westwood; Anna-Lena Berg
Journal:  J Toxicol Pathol       Date:  2014-04-30       Impact factor: 1.628

6.  A case of venlafaxine-induced interstitial lung disease.

Authors:  Serim Oh; Seung-Ick Cha; Hyera Kim; Minjung Kim; Sun Ha Choi; Hyewon Seo; Tae-In Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-08-29

7.  Identification of drugs inducing phospholipidosis by novel in vitro data.

Authors:  Markus Muehlbacher; Philipp Tripal; Florian Roas; Johannes Kornhuber
Journal:  ChemMedChem       Date:  2012-09-03       Impact factor: 3.466

8.  Phospholipogenic pharmaceuticals are associated with a higher incidence of histological findings than nonphospholipogenic pharmaceuticals in preclinical toxicology studies.

Authors:  Linda R Barone; Scott Boyer; James R Damewood; James Fikes; Paul J Ciaccio
Journal:  J Toxicol       Date:  2012-06-14

Review 9.  Depression in pulmonary arterial hypertension and interstitial lung diseases.

Authors:  Sameer Verma; Jose Cardenas-Garcia; Prasanta R Mohapatra; Arunabh Talwar
Journal:  N Am J Med Sci       Date:  2014-06

Review 10.  Interstitial lung disease associated with drug therapy.

Authors:  P Camus; S Kudoh; M Ebina
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.